IL4 and Mental deterioration: AD patients with intermediate cognitive decline showed significantly higher levels of IL-2 (p = 0.021), IL-4 (p = 0.016), IFN-γ (p = 0.018) and PDGF (p = 0.031) compared to those with slow cognitive decline over one year (Figure 2 and Table 5).